Login / Signup

Specific T-cell responses for guiding treatment with convalescent plasma in severe COVID-19 and humoral immunodeficiency: a case report.

Katarina NyströmMaria HjorthRamona FustÅsa Nilsdotter-AugustinssonMarie LarssonKatarina NiwardSofia Nyström
Published in: BMC infectious diseases (2022)
Assessment of SARS-CoV-2T-cell responses can facilitate the clinical management of COVID-19 patients with humoral immunodeficiencies.
Keyphrases
  • sars cov
  • immune response
  • coronavirus disease
  • respiratory syndrome coronavirus
  • early onset
  • replacement therapy
  • drug induced